Richard Mohs, AgeneBio VP for Clinical Development, Presents at 2021 NIH Alzheimer Disease Summit

Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.

« back to Press Releases

April 21, 2021

Richard Mohs, AgeneBio VP for Clinical Development, Presents at 2021 NIH Alzheimer Disease Summit

AGB101 to Slow the Progression of MCI in Alzheimer’s Disease